dr. emens on the combination of checkpoint inhibitors and parp inhibitors in ovarian cancer
Published 4 years ago • 105 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
6:25
combinations with parp inhibitors for ovarian cancer
-
1:12
dr. emens on immune-related adverse events in ovarian cancer
-
59:14
parp inhibitors in ovarian cancer: clinical updates from sgo 2023
-
0:56
dr. crane on combinations with parp inhibitors in ovarian cancer
-
0:56
dr. levine on combos with parp inhibitors in ovarian cancer
-
54:40
parp inhibitors in 2020: where are we now, and where are we going | webinar | ambry genetics
-
58:46
learn all about parp inhibitors with dr jon krell, consultant medical oncologist
-
1:03:39
precision medicine in ovarian cancer with parp inhibitor therapy and companion diagnostics
-
2:03
dr. moore on treatment for patients with ovarian cancer who develop resistance to parp inhibitors
-
1:08
dr. essel on repeat use of parp inhibitors in ovarian cancer
-
0:53
dr. mirza on the impact of parp inhibitors in ovarian cancer
-
2:38
assessing the role of parp inhibitors and immunotherapy in ovarian cancer
-
0:59
dr. simeone on impact of parp inhibitors on pancreatic cancer
-
2:30
dr. matulonis on toxicities with parp inhibitors in ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
5:53
combining parp inhibitors checkpoint inhibitors in tnbc
-
1:22
dr. gunderson on the use of parp inhibitors in all-comers with ovarian cancer
-
0:41
understand the adverse events of parp inhibitors
-
1:38
dr. mccann on combination trials with parp inhibitors in ovarian cancer
-
2:23
dr. moore on unanswered questions with parp inhibitors in ovarian cancer
-
3:44
the future role of parp inhibition in ovarian cancer